Vertical integration, consolidation of payers as promotion of health business – mergers and…
Alexion Pharma"$ 40 Billion Sale" AstraZeneca (Nasdaq: AZN) and Immune medicine'$ 20 billion sale Gilead Sciences (Nasdaq: GOLD) last year helped set expectations high in a healthcare company. Will the party go on? Trends such as…